<DOC>
	<DOCNO>NCT00003939</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness ecteinascidin 743 treat patient advanced soft tissue sarcoma .</brief_summary>
	<brief_title>Ecteinascidin 743 Treating Patients With Advanced Soft Tissue Sarcoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine therapeutic activity ecteinascidin 743 patient advanced soft tissue sarcoma . II . Determine duration response patient . III . Determine acute side effect patient . OUTLINE : This multicenter study . Patients receive ecteinascidin 743 ( ET-743 ) IV 24 hour every 3 week . Treatment continue least 2-6 course absence disease progression unacceptable toxicity . Patients follow every 6 week disease progression every 12 week disease progression . PROJECTED ACCRUAL : Approximately 28-44 patient accrue study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<mesh_term>Intestinal Neoplasms</mesh_term>
	<mesh_term>Trabectedin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven soft tissue sarcoma , include follow cell type : Malignant fibrous histiocytoma Liposarcoma Rhabdomyosarcoma Synovial sarcoma Malignant paraganglioma Fibrosarcoma Leiomyosarcoma Angiosarcoma include hemangiopericytoma Neurogenic sarcoma Unclassified sarcoma Miscellaneous sarcoma include mixed mesodermal tumor uterus Cell type NOT allow : Malignant mesothelioma Chondrosarcoma Neuroblastoma Osteosarcoma Ewing 's sarcoma Embryonal rhabdomyosarcoma Measurable lesion evidence progression within 6 week prior study ( osseous lesion , hepatomegaly , lymphedema , ascites , pleural lesion consider measurable ) No symptomatic know CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : WHO 01 Life expectancy : Not specify Hematopoietic : Neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.75 mg/dL Albumin least 2.5 g/dL AST ALT less 1.5 time upper limit normal ( ULN ) ( 2.5 time ULN liver metastasis present ) Alkaline phosphatase less 2.5 time ULN No significant hepatic disease ( e.g. , active hepatitis , cirrhosis , etc . ) Renal : Creatinine great 1.36 mg/dL OR Creatinine clearance least 60 mL/min Cardiovascular : No prior cardiovascular disease Other : No severe medical illness No psychosis No prior concurrent second primary malignant tumor , except adequately treat carcinoma situ cervix basal cell carcinoma Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since prior chemotherapy No 1 prior regimen combination chemotherapy OR No 2 prior single agent regimens No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy sole index lesion No concurrent radiotherapy Surgery : Not specify Other : No concurrent investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>adult angiosarcoma</keyword>
	<keyword>adult fibrosarcoma</keyword>
	<keyword>adult leiomyosarcoma</keyword>
	<keyword>adult liposarcoma</keyword>
	<keyword>adult neurofibrosarcoma</keyword>
	<keyword>adult synovial sarcoma</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>small intestine leiomyosarcoma</keyword>
	<keyword>adult alveolar soft-part sarcoma</keyword>
	<keyword>adult epithelioid sarcoma</keyword>
	<keyword>adult malignant fibrous histiocytoma</keyword>
	<keyword>adult malignant hemangiopericytoma</keyword>
	<keyword>adult malignant mesenchymoma</keyword>
	<keyword>adult rhabdomyosarcoma</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>uterine carcinosarcoma</keyword>
	<keyword>uterine leiomyosarcoma</keyword>
	<keyword>endometrial stromal sarcoma</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>adult meningeal hemangiopericytoma</keyword>
	<keyword>gastrointestinal stromal tumor</keyword>
</DOC>